Psychemedics CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Psychemedics Corporation announced its Q3 2024 financial results, alongside a plan to go private through a reverse/forward stock split and delisting from the Nasdaq.
Psychemedics Corporation reported a decrease in revenue and profit for Q2 2024 and announced a plan to go private through a reverse/forward stock split and delisting from the Nasdaq.
Psychemedics Corporation experienced a 9% decrease in revenue in the first quarter of 2024 compared to the same period in 2023, primarily due to lower testing volumes.